aTyr Pharma, Inc. (NASDAQ:ATYR) Receives $17.00 Average Target Price from Analysts
aTyr Pharma, Inc. (NASDAQ:ATYR – Get Free Report) has been given an average recommendation of “Hold” by the eight brokerages that are presently covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, five have assigned a hold recommendation, one has assigned a buy recommendation and one […]
2 Aug 05:58 · The Cerbat Gem